A phase IIa double-blind, randomized, parallel-arm, placebo-controlled trial to investigate the effects of three dose levels of

A phase IIa double-blind, randomized, parallel-arm, placebo-controlled trial to investigate the effects of three dose levels of CIT-013 on disease activity in patients with moderately active rheumatoid arthritis.

Abierta

Código protocolo: CITRYLL002-Citydream
Código EudraCT: _
Grupo de investigación: Reumatología
Servicio: Reumatología
Investigador/a principal: Lopez Lasanta, Maria America
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II